{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:30Z","timestamp":1707525630525},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,18]]},"DOI":"10.7759\/cureus.50732","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T17:39:07Z","timestamp":1702921147000},"source":"Crossref","is-referenced-by-count":0,"title":["The Successful Treatment of Acute Kidney Injury Due to Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Without Glomeruli Involvement by Using Rituximab: A Case Report"],"prefix":"10.7759","author":[{"given":"Neeladri","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated vasculitis: Core Curriculum 2020","volume":"75","author":"Geetha D","year":"2020","unstructured":"Geetha D, Jefferson JA. ANCA-associated vasculitis: Core Curriculum 2020. Am J Kidney Dis. 2020, 75:124-37. 10.1053\/j.ajkd.2019.04.031","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv022","article-title":"Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"30","author":"Watts RA","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Su\u00e1rez LF. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015, 30:i14-22. 10.1093\/ndt\/gfv022","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X231197324","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis predominantly manifesting tubulointerstitial nephritis: a case report","volume":"11","author":"Nishioka K","year":"2023","unstructured":"Nishioka K, Yamaguchi S, Hashiguchi A, et al.. Antineutrophil cytoplasmic antibody-associated vasculitis predominantly manifesting tubulointerstitial nephritis: a case report. SAGE Open Med Case Rep. 2023, 11:4-6. 10.1177\/2050313X231197324","journal-title":"SAGE Open Med Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-013-0103-0","article-title":"AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change","volume":"3","author":"Kasahara H","year":"2014","unstructured":"Kasahara H, Hiroyuki N, Shinohara M, Koike T. AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change. CEN Case Rep. 2014, 3:1-4. 10.1007\/s13730-013-0103-0","journal-title":"CEN Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-009-0200-8","article-title":"Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis","volume":"13","author":"Nakabayashi K","year":"2009","unstructured":"Nakabayashi K, Sumiishi A, Sano K, et al.. Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis. Clin Exp Nephrol. 2009, 13:605-13. 10.1007\/s10157-009-0200-8","journal-title":"Clin Exp Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.02.030","article-title":"The antineutrophil cytoplasmic antibody-associated vasculitides","volume":"117","author":"Seo P","year":"2004","unstructured":"Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004, 117:39-50. 10.1016\/j.amjmed.2004.02.030","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021, 100.S1-S276. 10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.11.942","article-title":"Effect of diagnostic delay on disease severity and outcome in glomerulonephritis caused by anti-neutrophil cytoplasmic antibodies","volume":"49","author":"Lal DP","year":"1996","unstructured":"Lal DP, O'Donoghue DJ, Haeney M. Effect of diagnostic delay on disease severity and outcome in glomerulonephritis caused by anti-neutrophil cytoplasmic antibodies. J Clin Pathol. 1996, 49:942-4. 10.1136\/jcp.49.11.942","journal-title":"J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6369814","article-title":"Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study","volume":"2018","author":"Salmela A","year":"2018","unstructured":"Salmela A, T\u00f6rnroth T, Poussa T, Ekstrand A. Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study. Int J Nephrol. 2018, 2018:24-6. 10.1155\/2018\/6369814","journal-title":"Int J Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021, 73:1366-83. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010046","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement","volume":"26","author":"Geetha D","year":"2015","unstructured":"Geetha D, Specks U, Stone JH, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol. 2015, 26:976-85. 10.1681\/ASN.2014010046","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life","volume":"34","author":"Pugnet G","year":"2016","unstructured":"Pugnet G, Pagnoux C, Terrier B, et al.. Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life. Clin Exp Rheumatol. 2016, 34:S54-9.","journal-title":"Clin Exp Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin L","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A, et al.. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014, 371:1771-80. 10.1056\/NEJMoa1404231","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211323-the-successful-treatment-of-acute-kidney-injury-due-to-antineutrophil-cytoplasmic-antibody-anca-associated-vasculitis-without-glomeruli-involvement-by-using-rituximab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:24Z","timestamp":1707509424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211323-the-successful-treatment-of-acute-kidney-injury-due-to-antineutrophil-cytoplasmic-antibody-anca-associated-vasculitis-without-glomeruli-involvement-by-using-rituximab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.50732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}